NKG2-C type II integral membrane protein is a protein that in humans is encoded by the KLRC2gene.
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The group, designated KLRC (NKG2) are expressed primarily in natural killer (NK) cells and encodes a family of transmembrane proteins characterized by a type II membrane orientation (extracellular C terminus) and the presence of a C-type lectin domain. The KLRC (NKG2) gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed on NK cells. KLRC2 alternative splice variants have been described but their full-length nature has not been determined.
^Lazetic, S; Chang C, Houchins J P, Lanier L L, Phillips J H (Dec. 1996). "Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits". J. Immunol. (UNITED STATES) 157 (11): 4741–5. ISSN0022-1767. PMID8943374.
Houchins JP, Yabe T, McSherry C, Bach FH (1991). "DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells". J. Exp. Med.173 (4): 1017–20. doi:10.1084/jem.173.4.1017. PMC2190798. PMID2007850.
Yabe T, McSherry C, Bach FH et al. (1993). "A multigene family on human chromosome 12 encodes natural killer-cell lectins". Immunogenetics37 (6): 455–60. doi:10.1007/BF00222470. PMID8436421.
Houchins JP, Lanier LL, Niemi EC et al. (1997). "Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C". J. Immunol.158 (8): 3603–9. PMID9103421.
Braud VM, Allan DS, O'Callaghan CA et al. (1998). "HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C". Nature391 (6669): 795–9. doi:10.1038/35869. PMID9486650.
Glienke J, Sobanov Y, Brostjan C et al. (1998). "The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex". Immunogenetics48 (3): 163–73. doi:10.1007/s002510050420. PMID9683661.
Ding Y, Sumitran S, Holgersson J (1999). "Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells". Scand. J. Immunol.49 (5): 459–65. doi:10.1046/j.1365-3083.1999.00566.x. PMID10320637.
Khakoo SI, Rajalingam R, Shum BP et al. (2000). "Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans". Immunity12 (6): 687–98. doi:10.1016/S1074-7613(00)80219-8. PMID10894168.
Shum BP, Flodin LR, Muir DG et al. (2002). "Conservation and variation in human and common chimpanzee CD94 and NKG2 genes". J. Immunol.168 (1): 240–52. PMID11751968.
Strausberg RL, Feingold EA, Grouse LH et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A.99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC139241. PMID12477932.
Hikami K, Tsuchiya N, Yabe T, Tokunaga K (2003). "Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population". Genes Immun.4 (2): 160–7. doi:10.1038/sj.gene.6363940. PMID12618865.
Miyashita R, Tsuchiya N, Hikami K et al. (2004). "Molecular genetic analyses of human NKG2C (KLRC2) gene deletion". Int. Immunol.16 (1): 163–8. doi:10.1093/intimm/dxh013. PMID14688071.
Gerhard DS, Wagner L, Feingold EA et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res.14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC528928. PMID15489334.
Gumá M, Busch LK, Salazar-Fontana LI et al. (2005). "The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells". Eur. J. Immunol.35 (7): 2071–80. doi:10.1002/eji.200425843. PMID15940674.